{"prompt": "['IRB Approved', 'Document Release Date: 02/26/2020', 'CC Protocol Number: 9582', 'PI: Michael T. Schweizer, MD', 'Apalutamide in Active Surveillance patients', 'Protocol Version: 6.0; September 06, 2019', '9.5.1.', '62', 'Printed on 1/29/2021']['IRB Approved', 'Document Release Date: 02/26/2020', 'CC Protocol Number: 9582', 'PI: Michael T. Schweizer, MD', 'Apalutamide in Active Surveillance patients', 'Protocol Version: 6.0; September 06, 2019', '9.5.2.', '63', 'Printed on 1/29/2021']['IRB Approved', 'Document Release Date: 02/26/2020', 'CC Protocol Number: 9582', 'PI: Michael T. Schweizer, MD', 'Apalutamide in Active Surveillance patients', 'Protocol Version: 6.0; September 06, 2019', '9.5.3.', '9.6. Evaluating Adverse Events', 'The grade and severity of the event will be determined using the NCI Common', 'Terminology Criteria for Adverse Events, CTCAE version 4.03. A copy of the CTCAE', 'version 4.03 can be downloaded from the CTEP home page (http://ctep.cancer.gov). All', 'appropriate treatment areas should have access to a copy of the CTCAE version 4.03.', 'Adverse events must be defined using CTCAE criteria. Adverse events not included in', 'the CTCAE version 4.03 should be reported and graded under the \"Other\" adverse', 'event within the appropriate category and grade 1 to 5 according to the general grade', 'definitions, mild, moderate, severe, life-threatening, fatal, as provided in the CTCAE', 'version 4.03.', '9.6.1. Determining if the event is expected or unexpected', 'The determination of whether an AE is expected is based on agent-specific adverse', 'event information provided in Section 7and 8 Pharmaceutical Information. Unexpected', 'AEs are those not listed in the agent-specific adverse event information provided in', 'Section 7and 8 Pharmaceutical Information.', '9.6.2. Relationship to the medical treatment or procedure', 'The Investigator should document his/her opinion of the relationship of the event to', 'study medication as follows:', 'Unrelated- The adverse event is clearly not related to the investigational', 'agent(s).', 'Unlikely- The adverse event is doubtfully related to the investigational', 'agent(s).', 'Possible-The adverse event may be related to the investigational agent(s).', '64', 'Printed on 1/29/2021']\n\n###\n\n", "completion": "END"}